Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-028892
Filing Date
2025-06-02
Accepted
2025-06-02 19:20:51
Documents
3
Period of Report
2025-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1748906445.html 4  
1 FORM 4 wk-form4_1748906445.xml 4 5515
2 EX-24 hatfield-form144andsecti.htm EX-24 3067
3 hatfield-form144andsecti001.jpg GRAPHIC 190210
  Complete submission text file 0001628280-25-028892.txt   272094
Mailing Address 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Hatfield Jeffrey S. (Reporting) CIK: 0001609879 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 251016758

Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)